US Nuclear Corp (OTC: UCLE) has filed its Form 10-Q for the first quarter of 2026, reporting a 72% reduction in loss from operations compared to the same period in 2025, according to a company press release. The company also expects to file its second-quarter report within the next three to four weeks. However, trading in the company's stock will not resume until after the release of its third-quarter results, which are projected for the first week of December.
The delay in quarterly filings stems from issues that pushed the release of the 2025 annual report to June, according to Michael Hastings, CFO of US Nuclear. "We have been working very hard to correct the issues which delayed the release of the 2025 10K until June, impacting the timely release of the second and third-quarter filings," Hastings said. He noted that the company lost key personnel after closing its Los Angeles operation, complicating the retrieval of financial data, and also replaced some staff at its Overhoff subsidiary. A new auditor made recommendations that are taking time to implement, but Hastings said the company is committed to making reporting faster and more efficient.
The first-quarter financial close and review process took about four months, far exceeding the 45-day window from the close of the period. The second-quarter filing is also delayed, but the company is actively engaged in the review process and working with its internal team and independent auditors to finalize it as quickly as possible. For a complete list of risks, the company points to its US Nuclear Form 10K_December 31, 2025.
Despite the filing delays, US Nuclear highlighted several operational improvements it believes will make 2027 a record year. The company engaged a skilled General Manager/COO in June who is streamlining logistics, clearing backlogs, and accelerating product and service delivery. Company backlog has grown to $1.2 million and is expected to finish the year at $2.9 million. US Nuclear is also interviewing outsourced CPA firms to ensure accurate and timely financial reporting, with selection and onboarding expected imminently.
The company reduced its loss from operations by over $375,000, or 72%, compared to the same period in 2025, and aims to maintain that improvement over the full year. The GM is using four college interns to conduct a full marketing and product analysis of the TA/Optron product line, which was built in Los Angeles, for the purpose of re-launching the products in January 2027, with the hope of adding $600,000 in revenues that year. Additionally, the company started discussions this summer with other companies regarding potential joint ventures, a purchase of US Nuclear by a larger company, or a reverse merger with a synergistic company interested in going public.
Management expects 2027 sales and profits to increase 20-30%, with sales doubling the current level in 2028, or significantly higher if a transaction is completed in 2027. The company's first-quarter results are detailed in its US Nuclear Form 10Q_March 31, 2026. The original release can be viewed on www.newmediawire.com.
For investors, the news signals both progress and caution. The sharp reduction in operating loss suggests cost-cutting and operational improvements are taking effect, but the delayed filings and continued stock halt pose liquidity and transparency risks. The company's forward-looking statements involve risks and uncertainties, including macroeconomic changes, supply chain disruptions, market demand, and its ability to raise capital and retain personnel. US Nuclear undertakes no obligation to update these statements after the date of the release.
